Watchlists Portfolios Alerts Pricing Sign in Get started

Menu

Market-Moving News for September 11th

Benzinga Newsdesk Sep 11, 2025 1 year ago

MoversTrading Ideas

SLXN: 50% | Silexion Highlights Preclinical Data Of SIL204 Supporting Dual-Route Treatment Strategy With Phase 2/3 Trial On Track For 2026 VNCE: 242% | Vince Holding Q2 Adj. EPS $0.38 Beats $(0.10)

SLXN: 50% | Silexion Highlights Preclinical Data Of SIL204 Supporting Dual-Route Treatment Strategy With Phase 2/3 Trial On Track For 2026

VNCE: 242% | Vince Holding Q2 Adj. EPS $0.38 Beats $(0.10) Estimate, Sales $73.241M Beat $72.882M Estimate

AMST: 169% | Amesite Reports 63% Revenue Growth As NurseMagic Enterprise Sales Surpass Consumer Business, Launches AI Tool To Automate Government Form Filing For Healthcare Providers

Read the original